Emergence of New ALK Mutations at Relapse of Neuroblastoma.

Gudrun Schleiermacher; Niloufar Javanmardi; Virginie Bernard; Quentin Leroy; Julie Cappo; Thomas Rio Frio; Gaelle Pierron; Eve Lapouble; Valérie Combaret; Frank Speleman; Bram de Wilde; Anna Djos; Ingrid Øra; Fredrik Hedborg; Catarina Träger; Britt-Marie Holmqvist; Jonas Abrahamsson; Michel Peuchmaur; Jean Michon; Isabelle Janoueix-Lerosey; Per Kogner; Olivier Delattre; Tommy Martinsson

doi:10.1200/JCO.2013.54.0674

Emergence of New ALK Mutations at Relapse of Neuroblastoma.

Gudrun Schleiermacher, Niloufar Javanmardi, Virginie Bernard, Quentin Leroy, Julie Cappo, Thomas Rio Frio, Gaelle Pierron, Eve Lapouble, Valérie Combaret, Frank Speleman, Bram de Wilde, Anna Djos, Ingrid Øra, Fredrik Hedborg, Catarina Träger, Britt-Marie Holmqvist, Jonas Abrahamsson, Michel Peuchmaur, Jean Michon, Isabelle Janoueix-LeroseyPer Kogner, Olivier Delattre, Tommy Martinsson

Paediatrics (Lund)

Research output: Contribution to journal › Article › peer-review

Abstract

In neuroblastoma, the ALK receptor tyrosine kinase is activated by point mutations. We investigated the potential role of ALK mutations in neuroblastoma clonal evolution.

Original language	English
Pages (from-to)	2727
Journal	Journal of Clinical Oncology
Volume	32
Issue number	25
DOIs	https://doi.org/10.1200/JCO.2013.54.0674
Publication status	Published - 2014

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2013.54.0674

http://www.ncbi.nlm.nih.gov/pubmed/25071110?dopt=Abstract

Cite this

Schleiermacher, G., Javanmardi, N., Bernard, V., Leroy, Q., Cappo, J., Rio Frio, T., Pierron, G., Lapouble, E., Combaret, V., Speleman, F., de Wilde, B., Djos, A., Øra, I., Hedborg, F., Träger, C., Holmqvist, B.-M., Abrahamsson, J., Peuchmaur, M., Michon, J., ... Martinsson, T. (2014). Emergence of New ALK Mutations at Relapse of Neuroblastoma. Journal of Clinical Oncology, 32(25), 2727. https://doi.org/10.1200/JCO.2013.54.0674

@article{fef4ddd36e2f46ff9b2d60655c083a8b,

title = "Emergence of New ALK Mutations at Relapse of Neuroblastoma.",

abstract = "In neuroblastoma, the ALK receptor tyrosine kinase is activated by point mutations. We investigated the potential role of ALK mutations in neuroblastoma clonal evolution.",

author = "Gudrun Schleiermacher and Niloufar Javanmardi and Virginie Bernard and Quentin Leroy and Julie Cappo and {Rio Frio}, Thomas and Gaelle Pierron and Eve Lapouble and Val{\'e}rie Combaret and Frank Speleman and {de Wilde}, Bram and Anna Djos and Ingrid {\O}ra and Fredrik Hedborg and Catarina Tr{\"a}ger and Britt-Marie Holmqvist and Jonas Abrahamsson and Michel Peuchmaur and Jean Michon and Isabelle Janoueix-Lerosey and Per Kogner and Olivier Delattre and Tommy Martinsson",

year = "2014",

doi = "10.1200/JCO.2013.54.0674",

language = "English",

volume = "32",

pages = "2727",

journal = "Journal of Clinical Oncology",

issn = "1527-7755",

publisher = "Lippincott Williams & Wilkins",

number = "25",

}

Schleiermacher, G, Javanmardi, N, Bernard, V, Leroy, Q, Cappo, J, Rio Frio, T, Pierron, G, Lapouble, E, Combaret, V, Speleman, F, de Wilde, B, Djos, A, Øra, I, Hedborg, F, Träger, C, Holmqvist, B-M, Abrahamsson, J, Peuchmaur, M, Michon, J, Janoueix-Lerosey, I, Kogner, P, Delattre, O & Martinsson, T 2014, 'Emergence of New ALK Mutations at Relapse of Neuroblastoma.', Journal of Clinical Oncology, vol. 32, no. 25, pp. 2727. https://doi.org/10.1200/JCO.2013.54.0674

TY - JOUR

T1 - Emergence of New ALK Mutations at Relapse of Neuroblastoma.

AU - Schleiermacher, Gudrun

AU - Javanmardi, Niloufar

AU - Bernard, Virginie

AU - Leroy, Quentin

AU - Cappo, Julie

AU - Rio Frio, Thomas

AU - Pierron, Gaelle

AU - Lapouble, Eve

AU - Combaret, Valérie

AU - Speleman, Frank

AU - de Wilde, Bram

AU - Djos, Anna

AU - Øra, Ingrid

AU - Hedborg, Fredrik

AU - Träger, Catarina

AU - Holmqvist, Britt-Marie

AU - Abrahamsson, Jonas

AU - Peuchmaur, Michel

AU - Michon, Jean

AU - Janoueix-Lerosey, Isabelle

AU - Kogner, Per

AU - Delattre, Olivier

AU - Martinsson, Tommy

PY - 2014

Y1 - 2014

N2 - In neuroblastoma, the ALK receptor tyrosine kinase is activated by point mutations. We investigated the potential role of ALK mutations in neuroblastoma clonal evolution.

AB - In neuroblastoma, the ALK receptor tyrosine kinase is activated by point mutations. We investigated the potential role of ALK mutations in neuroblastoma clonal evolution.

U2 - 10.1200/JCO.2013.54.0674

DO - 10.1200/JCO.2013.54.0674

M3 - Article

C2 - 25071110

SN - 1527-7755

VL - 32

SP - 2727

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 25

ER -

Emergence of New ALK Mutations at Relapse of Neuroblastoma.

Abstract

Subject classification (UKÄ)

UN SDGs

Access to Document

Fingerprint

Cite this